Bronchodilator Agents: all 1,999 studies that test it

Page 6 of 20. Open to participants first (185), then studies with results posted, then the rest; newest registration first within each.

• Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose CombinationCompletedNCT01462942Phase 3Results posted
• 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years OldCompletedNCT01462344Phase 4Results posted
• Safety and Maintenance Study of Entocort for Children With Crohn's DiseaseCompletedNCT01453946Phase 3Results posted
• Inhaled Fluticasone Furoate/Vilanterol Safety and Tolerability, PK and PD StudyCompletedNCT01453023Phase 2Results posted
• Safety Study of Entocort for Children With Crohn's DiseaseCompletedNCT01444092Phase 3Results posted
• An Allergen BioCube (ABC) Study Evaluating the Efficacy of Fluticasone Propionate Nasal Spray Compared to PlaceboCompletedNCT01439815Phase 4Results posted
• Long-acting Beta Agonist Step Down StudyCompletedNCT01437995Phase 4Results posted
• Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseCompletedNCT01437540Phase 3Results posted
• Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01437397Phase 3Results posted
• Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With AsthmaCompletedNCT01436110Phase 3Results posted
• Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With AsthmaCompletedNCT01436071Phase 3Results posted
• Evaluating the Efficacy and Safety of Fluticasone Furoate in the Treatment of Asthma in Adults and AdolescentsCompletedNCT01431950Phase 3Results posted
• Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01431287Phase 3Results posted
• Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01431274Phase 3Results posted
• Preventative Omalizumab or Step-up Therapy for Severe Fall ExacerbationsCompletedNCT01430403Phase 4Results posted
• Intranasal SB-705498 in Allergic Rhinitis (AR) PatientsCompletedNCT01424397Phase 2Results posted
• Cilostazol Augmentation Study in DementiaCompletedNCT01409564Phase 4Results posted
• Methemoglobin Levels in Generally Anesthetized Pediatric Dental Patients Receiving Local AnestheticsCompletedNCT01402869Not applicableResults posted
• Efficacy of Inhaling Bronchodilator Medications in Chronic Obstructive Pulmonary DiseaseCompletedNCT01391559Not applicableResults posted
• A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate AsthmaCompletedNCT01383499Phase 2Results posted
• Measurement of Bispectral Index and Awareness in Patients Undergoing Electrophysiology Studies With IsoproterenolCompletedNCT01377636Not applicableResults posted
• A 24-week Study of Fluticasone Furoate/Vilanterol Inhalation Powder in Subjects of Asian Ancestry With COPDCompletedNCT01376245Phase 3Results posted
• Study to Assess the Absorption and Tolerability of Intranasal Ketorolac Tromethamine and to Assess the Effects of Oxymetazoline Hydrochloride and Fluticasone Propionate on the Absorption and Tolerability of Intranasal Ketorolac Tromethamine in Participants With Allergic RhinitisCompletedNCT01365650Phase 1Results posted
• Open Label Study to Assess the Pharmacokinetics of Intranasal Ketorolac Tromethamine Following Fluticasone Propionate in Healthy SubjectsCompletedNCT01365611Phase 1Results posted
• New Breath Actuated MDI Symbicort Compared to Symbicort pMDI and Budesonide pMDI for 12 Weeks Twice a DayCompletedNCT01360021Phase 3Results posted
• A Study to Evaluate the 24 Hour Spirometric Effect (FEV1) of Fluticasone Furoate/Vilanterol Inhalation Powder (100mcg Fluticasone Furoate (FF)/25mcg Vilanterol (VI)) Compared With Salmeterol/Fluticasone Propionate Inhalation Powder (50mcg Salmeterol/500mcg Fluticasone Propionate (FP))CompletedNCT01342913Phase 3Results posted
• A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPDCompletedNCT01336608Phase 3Results posted
• Attenuation of the Side Effect Profile of Regadenoson: Study With Aminophylline in Patients With Severe Kidney Disease Undergoing Myocardial Perfusion ImagingCompletedNCT01336140Phase 4Results posted
• Pharmacokinetics and PharmacoDynamics of GW685698 in Paedeatric Asthmatic PatientsCompletedNCT01332292Phase 2Results posted
• Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT01323634Phase 3Results posted
• Study Evaluating the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01323621Phase 3Results posted
• Efficacy and Safety of Increasing Doses of Inhaled Albuterol in Children With Acute Wheezing EpisodesCompletedNCT01323010Not applicableResults posted
• Efficacy and Safety of 2 Doses of Tiotropium Via Respimat in Adult Patients With Mild Persistent AsthmaCompletedNCT01316380Phase 3Results posted
• Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT01313676Phase 3Results posted
• Targeted Therapy of Bronchiolitis Obliterans SyndromeCompletedNCT01307462Phase 2Results posted
• Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT)CompletedNCT01290874Phase 3Results posted
• A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic RhinitisCompletedNCT01279057Phase 3Results posted
• NasoNeb Delivery of an Intranasal SteroidCompletedNCT01270256Phase 4Results posted
• A Study of LY2216684 in Healthy Participants Receiving Albuterol or PropanololCompletedNCT01263197Phase 1Results posted
• A Study of LY2216684 and Theophylline in Healthy SubjectsCompletedNCT01263106Phase 1Results posted
• A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2)CompletedNCT01258803Phase 2Results posted
• Preliminary Efficacy and Safety Study of Oral Nepadutant in Infant ColicCompletedNCT01258153Phase 2Results posted
• Respiratory Impedance and Obliterative BronchiolitisCompletedNCT01255449Not applicableResults posted
• Study With Aminophylline to Attenuate of the Side Effects of RegadenosonTerminatedNCT01250496Phase 4Results posted
• Aminophylline to Prevent Acute Kidney Injury in Children After Cardiac SurgeryCompletedNCT01245595Not applicableResults posted
• Effectiveness Study of Different Local Anesthetic MixturesCompletedNCT01243112Phase 4Results posted
• Randomised, Double- Blind, Cross-over Efficacy and Safety Comparison of Three Different Doses of Tiotropium Administered Once Daily Versus Placebo in Patients With Moderate Persistent Asthma.CompletedNCT01233284Phase 2Results posted
• A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Nasal Spray for 2 Weeks in Chinese Adult and Adolescent Subjects With Allergic RhinitisCompletedNCT01231464Phase 3Results posted
• Interactive Acute Smooth Muscle Effects of Salmeterol and Fluticasone in the AirwayCompletedNCT01231230Not applicableResults posted
• Inhaled Nitric Oxide (iNO) as an Adjunct to Neonatal ResuscitationCompletedNCT01220687Not applicableResults posted
• Acute Airway Vascular Smooth Muscle Effects of Inhaled BudesonideCompletedNCT01219738Not applicableResults posted
• A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed DosingTerminatedNCT01218009Phase 3Results posted
• Optimal Albuterol Regimens for Acute Asthma Exacerbations: DBRCT Pilot StudyCompletedNCT01196377Not applicableResults posted
• Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.CompletedNCT01194479Not applicableResults posted
• Effectiveness of Atropine and Glycopyrrolate to Reduce Hyper Salivation With Ketamine SedationCompletedNCT01191398Not applicableResults posted
• A Non-inferiority, Comparative Study Between Foraseq®, Eurofarma´s Formoterol/Budesonide and Alenia® in AsthmaCompletedNCT01167010Phase 3Results posted
• Nitric Oxide, GeNO Nitrosyl Delivery SystemCompletedNCT01165047Phase 2Results posted
• Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and AdolescentsCompletedNCT01159912Phase 3Results posted
• A Randomised, Double- Blind, Placebo Controlled, Cross-over Efficacy and Safety Comparison of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for Four Weeks in Patients With Moderate Persistent AsthmaCompletedNCT01152450Phase 2Results posted
• Effect of Nebulized Bronchodilators on Heart RateCompletedNCT01151579Phase 4Results posted
• Characterization of Placebo Responses in Stable AsthmaCompletedNCT01143688Not applicableResults posted
• Pharmacokinetics (PK) Study of Epinephrine Inhalation Aerosol in Healthy VolunteersCompletedNCT01143051Phase 1/2Results posted
• A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With PlaceboCompletedNCT01136382Phase 2Results posted
• Randomised Study Comparing the Effects of Inhaled FF/GW642444M Combination, FF and GW642444M on an Allergen Induced Asthmatic ResponseCompletedNCT01128595Phase 2Results posted
• Randomised Study Comparing the Effects of Inhaled Fluticasone Furoate (FF)/Vilanterol (VI; GW642444M) Combination and FF on an Allergen Induced Asthmatic ResponseCompletedNCT01128569Phase 2Results posted
• Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary DiseaseCompletedNCT01126437Phase 3Results posted
• Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate AsthmaCompletedNCT01122680Phase 2Results posted
• Long Term Safety and Tolerability of NVA237 Versus Tiotropium in Japanese PatientsCompletedNCT01119937Phase 3Results posted
• Sub-Sensitivity to Long-Acting Bronchodilators (LABA)CompletedNCT01117116Not applicableResults posted
• Bronchodilator Responsiveness in Obliterative BronchiolitisCompletedNCT01112241Phase 4Results posted
• Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization StudyCompletedNCT01110200Phase 4Results posted
• (CB-01-02/06) Oral Budesonide-Multi-Matrix System (MMX) 9mg Extended Release TabletsCompletedNCT01100112Phase 3Results posted
• Montelukast and Inhaled Nasal Steroid Tx in Adult Obstructive Sleep Apnea (OSA)CompletedNCT01089647Phase 3Results posted
• Asthma Exacerbation StudyCompletedNCT01086384Phase 3Results posted
• Effect of Epinephrine/ Phenylephrine for Preventing the Postreperfusion Syndrome During Reperfusion in Liver TransplantationCompletedNCT01080625Not applicableResults posted
• Effects of Tiotropium on Breathing Capacity and Exercise Limitation in Early Stages of Chronic Obstructive Pulmonary DiseaseCompletedNCT01072396Phase 4Results posted
• Trial on the Effect of Budesonide/Formoterol and Inhaled Budesonide Alone on Exercise-Induced AsthmaTerminatedNCT01070888Phase 4Results posted
• A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent AsthmaCompletedNCT01058863Phase 2Results posted
• Evaluate Onset of Effect in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Formoterol Turbuhaler®CompletedNCT01048333Phase 2Results posted
• Study to Evaluate the Safety and Efficacy of Formoterol in a Daily Dose of 18 µg (9 µg Twice Daily) in Japanese Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT01047553Phase 3Results posted
• Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry IICompletedNCT01040793Phase 3Results posted
• A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT01040728Phase 3Results posted
• Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT01040689Phase 3Results posted
• Determining Optimal Free Dose Combination of Tiotropium Bromide and BI 1744 CL in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01040403Phase 2Results posted
• Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry ICompletedNCT01040130Phase 3Results posted
• Medication Effects on Periurethral Sensation,Urethral Sphincter Activity and Pressure Flow ParametersCompletedNCT01028014Not applicableResults posted
• A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic RhinitisCompletedNCT01018862Phase 3Results posted
• Fluticasone Furoate/GW642444 Inhalation Powder Long-Term Safety StudyCompletedNCT01018186Phase 3Results posted
• A Study of the Safety and Efficacy of 4 Doses of BI 1744 CL Delivered Via the Respimat in Patients With Asthma.CompletedNCT01013753Phase 2Results posted
• Compare the Effects of Fluticasone Furoate Nasal Spray vs Placebo in Patients With Nasal Polypoid DiseaseTerminatedNCT01013701Phase 4Results posted
• Effect of Indacaterol on Inspiratory Capacity (IC)CompletedNCT01012765Phase 3Results posted
• Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or ProctosigmoiditisCompletedNCT01008423Phase 3Results posted
• Efficacy and Safety of Budesonide Foam for Participants With Active Mild to Moderate Ulcerative Proctitis or ProctosigmoiditisCompletedNCT01008410Phase 3Results posted
• Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy SymptomsCompletedNCT01007253Phase 4Results posted
• Comparison of the Effects of Indacaterol and Tiotropium on Inspiratory CapacityCompletedNCT00999908Phase 3Results posted
• Fluticasone Furoate Treatment of Daytime Somnolence and Cognitive Performance in Seasonal Allergic RhinitisCompletedNCT00997620Phase 4Results posted
• A Proof of Concept Study to Evaluate the Dose Response for the Systemic Benefit Risk Ratio of Inhaled Fluticasone Propionate in Chronic Obstructive Pulmonary DiseaseCompletedNCT00995475Phase 4Results posted
• Comparing Symbicort® As-Needed or Bricanyl As-Needed or Pulmicort® Once Daily + Bricanyl As-Needed in Asthma PatientsCompletedNCT00989833Phase 2Results posted
• Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00984659Phase 4Results posted
• Drug-Drug Interaction Study of Colchicine and TheophyllineCompletedNCT00983905Phase 1Results posted

← Bronchodilator Agents overview